Mikio Sato

发表

Phase II Clinical Study on Stent Therapy for Unresectable Malignant Colorectal Obstruction (JIVROSG-0206)

Y. Inaba, H. Yamaura, Yozo Sato, 2012, American journal of clinical oncology.

Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).

I. Hyodo, M. Shimada, M. Mizuta, 2016, Clinical colorectal cancer.

Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status

I. Hyodo, Yoshiyuki Yamamoto, M. Nishi, 2014, Medical Oncology.

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

I. Hyodo, Taketo Yamaguchi, K. Amagai, 2014, Gastric Cancer.

Phase I/II multicenter study of transarterial chemoembolization with a cisplatin fine powder and porous gelatin particles for unresectable hepatocellular carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401.

Y. Kodama, Y. Inaba, Y. Arai, 2012, Journal of Vascular and Interventional Radiology.

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302

Y. Kodama, Y. Inaba, M. Sone, 2022, Liver Cancer.

Neutrophilic dermatosis with necrobiotic changes as an unusual manifestation after the first shot of a COVID‐19 mRNA vaccine together with a high fever and liver injury

T. Tsunoda, Mikio Sato, S. Iijima, 2022, Journal of Cutaneous Immunology and Allergy.

Pancreaticoduodenal artery aneurysms associated with celiac axis stenosis due to compression by median arcuate ligament and celiac plexus

Mahmudul Hassan, Kaori Suzuki, A. Nakahara, 1998, Journal of Gastroenterology.

Transforming growth factor-alpha (TGF α)-producing gastric carcinoma with acanthosis nigricans: An endocrine effect of TGF α in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus

T. Iijima, Kazuho Ikeda, K. Fujiwara, 2005, Journal of Gastroenterology.

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

T. Yamanaka, E. Baba, N. Sugimoto, 2018, The oncologist.

Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).

E. Baba, N. Sugimoto, I. Hyodo, 2020, European journal of cancer.

Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer

H. Kiyozaki, K. Minashi, K. Amagai, 2021, Japanese journal of clinical oncology.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)

I. Hyodo, M. Shimada, Kazuma Kobayashi, 2019, International Journal of Clinical Oncology.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)

I. Hyodo, M. Shimada, Kazuma Kobayashi, 2019, International Journal of Clinical Oncology.